Alembic Pharma Pranav Amin MD Re-appointment Effective

Alembic Pharmaceuticals intimates BSE and NSE of Pranav Amin's Managing Director re-appointment effective 1st April 2026.
Shareholders approved the re-appointment at the 15th AGM on 5th August 2025 for a 5-year term, not liable to retire by rotation.
Pranav Amin (DIN: 00245099) heads International Business and is son of Chairman Mr. Chirayu Amin.
Company confirmed Pranav Amin is not debarred from directorship by any SEBI order or other authority.